Evidence map›Paper›PMID 27471271›Full record

ArticleThe Journal of biological chemistry2016

Glycosylation Alters Dimerization Properties of a Cell-surface Signaling Protein, Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM1).

You Zhuo, Jeong-Yeh Yang, Kelley W Moremen, James H Prestegard

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Site-to-site cross-talk in OST-B glycosylation of hCEACAM1-IgV.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Cells · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Pathogenic interactions betweenIranian journal of basic medical sciences · 2019
    Review
  18. Review
  19. Molecular Cloning and Bioinformatics Analysis ofInternational journal of molecular sciences · 2019
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

You ZhuoFrom the Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602.
Jeong-Yeh YangFrom the Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602.
Kelley W MoremenFrom the Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602.
James H PrestegardFrom the Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602 jpresteg@ccrc.uga.edu.
University of Georgia · US

Funding

TR&D3. Approaches to Proteoglycan Function at Biochemical and Cellular LevelsP41GM103390 · NIGMS · UNIVERSITY OF GEORGIA · PI MOREMEN, KELLEY W. · 2012 to 2019
$14.5M
NMR of Cell Surface OligosaccharidesR01GM033225 · NIGMS · YALE UNIVERSITY · PI PRESTEGARD, JAMES H. · 1985 to 2021
$4.6M
NIGMS NIH HHS P41 GM103390NIGMS NIH HHS R01 GM033225
6 · The paper itself

Abstract

Human carcinoembryonic antigen-related cell adhesion molecule 1 (C?/Au: EACAM1) is a cell-surface signaling molecule involved in cell adhesion, proliferation, and immune response. It is also implicated in cancer angiogenesis, progression, and metastasis. This diverse set of effects likely arises as a result of the numerous homophilic and heterophilic interactions that CEACAM1 can have with itself and other molecules. Its N-terminal Ig variable (IgV) domain has been suggested to be a principal player in these interactions. Previous crystal structures of the β-sandwich-like IgV domain have been produced using Escherichia coli-expressed material, which lacks native glycosylation. These have led to distinctly different proposals for dimer interfaces, one involving interactions of ABED β-strands and the other involving GFCC'C″ β-strands, with the former burying one prominent glycosylation site. These structures raise questions as to which form may exist in solution and what the effect of glycosylation may have on this form. Here, we use NMR cross-correlation measurements to examine the effect of glycosylation on CEACAM1-IgV dimerization and use residual dipolar coupling (RDC) measurements to characterize the solution structure of the non-glycosylated form. Our findings demonstrate that even addition of a single N-linked GlcNAc at potential glycosylation sites inhibits dimer formation. Surprisingly, RDC data collected on E. coli expressed material in solution indicate that a dimer using the non-glycosylated GFCC'C″ interface is preferred even in the absence of glycosylation. The results open new questions about what other factors may facilitate dimerization of CEACAM1 in vivo, and what roles glycosylation may play in heterophylic interactions.

Indexed as

Antigens, CDCell Adhesion MoleculesGlycosylationHEK293 CellsHumansNuclear Magnetic Resonance, BiomolecularProtein MultimerizationProtein Structure, QuaternaryProtein Structure, SecondaryAntigens, CDCD66 antigensCell Adhesion Moleculescell adhesiondimerizationglycosylationnuclear magnetic resonance (NMR)structural model

Identifiers

PMID27471271
PMCPMC5025693
OpenAlexW2520503827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.